Track the BioGaia AB share price and the full management transaction log of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, BioGaia AB has published 10 public disclosures. Market capitalisation: €12.2bn. The latest transaction was filed on 13 February 2026 (Purchase). Among the most active insiders: Anthon Jahreskog. The full history is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€100,356
9 ops.
Buy Volume
€199
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioGaia AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 165.00.
29Σ signal
Buys €100,356€199 Sells
Fundamental score
Ranked 6,380 of 28,803 companies
65.6
score / 100
Value
40
Quality
91
FCF yld2.6%
Earn yld2.9%
EV/EBITDA25.3x
ROE31%
Gross mgn73%
Net mgn22%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.